Please login to the form below

Not currently logged in
Email:
Password:

Astellas 'Changing Tomorrow' award winners

Astellas Pharma Europe launched its 'Changing Tomorrow' charity awards, and announced the first winners

Astellas Pharma Europe launched its 'Changing Tomorrow' charity awards, and announced the first winners.

The awards are designed to reward organisations working across all communities to help individuals realise their full potential and enhance their quality of life both now and in the future.

The first four recipients of the award, selected for the life-changing contributions they have made, are:
· CliniClowns – a Dutch organisation which arranges for clowns to visit sick children in hospital
· The International Foundation for Dermatology (IFD) – a non-profit organisation working to improve dermatologic care in rural areas of developing countries
· The Prostate Cancer Charity – the UK's leading voluntary organisation working with people affected by prostate cancer; and
· Save the Children – the Cyclone Nargis, Burma Fund.

Masao Yoshida, president and CEO of Astellas Pharma Europe, said: "Astellas takes its responsibility to society seriously and is committed to changing the lives of people around the world. We support worthwhile causes that make a difference; the four charities chosen to receive the Astellas 'Changing Tomorrow' charity awards are all striving to create a brighter future in their respective fields."

The 'Changing Tomorrow' awards are the latest initiative in Astellas' ethical commitment to support medical research and education on a global level. The company also runs a series of Corporate Social responsibility (CSR) programmes, which includes a registered charity supporting programmes and activities that will lead to a healthy society – the Astellas European Foundation.

Commenting on the award, John Neate, CEO of The Prostate Cancer Charity, said: "The Prostate Cancer Charity is delighted to have received this award and the associated funding. This contribution will help us to continue to raise awareness of prostate cancer and finance research, in addition to providing practical support and information to men affected by prostate cancer, the most common cancer in men in the UK, and their families."

24th September 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

Products come and go, but a pharma company’s most valuable, durable asset is its reputation, writes Duncan Mackenzie-Reid and Simon Grist
...
Erik
A quest for innovative solutions
UCB looks to the future through a PRISM...
Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...

Infographics